Precision Optics is finally shipping the programs it spent years designing, and the quarter ended March 31 showed what the factory looks like when those lines actually run. Systems manufacturing more than doubled and now dominates the mix, replacing the old pattern in which engineering retainers carried the top line while production stumbled on yields. Revenue reached $8.7 million. That print is a quarterly record and more than twice the year-ago period. The investment debate is whether that conversion is a durable manufacturing franchise or a two-customer spike that still needs equity to stay funded.
The tension sits under the headline. Two unnamed programs, a top-tier aerospace line and a single-use cystoscope, together supplied most of the quarter. Aerospace alone contributed $3.6 million. The cystoscope added $2.2 million. Gross margin recovered to 23.6 percent, but a Massachusetts hiring credit of about $0.2 million sat inside cost of goods and flattered the print. Sequential margin had been almost nothing the quarter before. The factory is loading, yet profitability still leans on mix, yield, and a grant.
Cash at quarter-end was $10.7 million after an oversubscribed March offering that priced common stock at $3.60 a share and lifted the share count above ten million. That raise retired the going-concern language that had appeared when cash was under $1 million at December 31. Management raised full-year revenue guidance into a $29 million to $31 million band, while still guiding adjusted earnings before interest, taxes, depreciation, and amortization to a loss. The next several months decide whether the ophthalmic follow-on order ships cleanly, whether aerospace and cystoscope volumes hold without another yield collapse, and whether the equity just raised is a bridge to self-funding or the start of another cycle.